Target intelligence / Profile preview

Inositol hexakisphosphate (IP6) and lower inositol phosphates (IP6)

Target
IP6
Molecular classification
Inositol phosphates, Phosphorylated polyols, Small molecules
01

Overview

Phytic acid, also known as inositol hexakisphosphate (IP6), and its lower phosphorylated derivatives (IP1-IP5) are naturally occurring compounds found in high concentrations in cereal grains, legumes, and oilseeds (PubChem CID 890). In biological systems, these molecules function as essential intracellular messengers involved in signal transduction, vesicle trafficking, and DNA repair (Vucenik & Shamsuddin, 2003). Phytic acid is particularly recognized for its potent antioxidant properties and its ability to chelate multivalent metal ions, which prevents the formation of hydroxyl radicals and inhibits the crystallization of calcium salts in the urine and vasculature (Grases et al., 2007). These properties make it a candidate for the prevention and treatment of kidney stones and cardiovascular calcification. Additionally, IP6 has shown significant anti-cancer activity by modulating cell cycle progression and promoting apoptosis in various tumor models (Bizzarri et al., 2016). Despite these benefits, phytic acid is often labeled an antinutrient because its high affinity for minerals can impair the absorption of essential elements like iron and zinc from the diet (Schlemmer et al., 2009).

Other names
PhytateMyo-inositol hexakisphosphateInositol phosphatesInsP6IP1-IP6Phytic acid
02

Mechanism of action

Chelation of multivalent metal ions (such as Ca2+, Fe2+/3+, and Zn2+) to inhibit oxidative stress and pathological calcification; modulation of intracellular signaling pathways including PI3K/Akt and PKC to regulate cell growth, differentiation, and apoptosis.

03

Biological functions

Signal transductionMineral homeostasisAntioxidant activityDNA repairVesicle traffickingCell cycle regulation
04

Disease associations

CancerNephrolithiasisVascular calcificationDiabetesMineral deficiency
05

Safety considerations

Reduced bioavailability of essential minerals (iron, zinc, calcium)Potential for mineral deficiencies in populations with low dietary intakeGastrointestinal discomfort at high supplemental doses
06

Interacting drugs

Calcium carbonate

3 more in the full profile.

07

Biomarkers

Urinary phytate concentrationPlasma inositol phosphate levels

Beyond the preview

Go deeper on Inositol hexakisphosphate (IP6) and lower inositol phosphates (IP6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inositol hexakisphosphate (IP6) and lower inositol phosphates (IP6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call